Sales revenue GC Pharma 2015-2024
In 2024, GC Pharma, also known as Green Cross, posted a sales revenue of around 1.68 trillion South Korean won. This represents a slight increase from the previous year.
Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2024 (in trillion South Korean won)
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$1,299 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Pharmaceutical drugs in South Korea
Overview
5
- Premium Statistic Pharmaceuticals market size South Korea 2013-2023
- Basic Statistic Pharmaceutical spending as share of GDP South Korea 1970-2023
- Basic Statistic Pharmaceutical spending per capita in South Korea 2000-2023
- Premium Statistic Pharmaceutical medications sales South Korea 2019-2022
- Premium Statistic Pharmaceutical medications institutional buyers in South Korea 2022
Production
6
- Basic Statistic Pharmaceuticals production value South Korea 2013-2023
- Premium Statistic Prescription drug products production value South Korea 2013-2023
- Premium Statistic Number of pharmaceutical manufacturers South Korea 2013-2023
- Premium Statistic Leading pharmaceutical companies South Korea 2023, by production value
- Premium Statistic Types of pharmaceutical drugs produced in South Korea 2023, by production value
- Premium Statistic Leading pharmaceutical products South Korea 2023, by production value
Distribution
6
- Premium Statistic Number of pharmaceutical distributors South Korea 2013-2023
- Premium Statistic Number of pharmaceutical distributors South Korea 2023, by type
- Premium Statistic Amount of medication supplied to medical facilities South Korea 2023, by supply value
- Premium Statistic Pharmaceutical medications used in healthcare institutions South Korea 2022, by ATC
- Premium Statistic Types of pharmaceutical drugs supplied to medical facilities in South Korea 2023
- Premium Statistic Types of pharmaceutical drugs supplied to pharmacies in South Korea 2023
Trade
7
- Premium Statistic Pharmaceutical export value from South Korea 2013-2023
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2023, by export value
- Premium Statistic Leading countries for drug product exports South Korea 2023, by export value
- Premium Statistic Pharmaceutical import value in South Korea 2013-2023
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2023, by import value
- Premium Statistic Leading countries for drug product imports South Korea 2023, by import value
- Premium Statistic Types of pharmaceutical drugs imported into South Korea 2023, by import value share
Market leaders
6
- Premium Statistic Leading pharmaceutical businesses South Korea 2023, by revenue
- Premium Statistic Sales revenue Yuhan 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2024
- Premium Statistic Sales revenue GC Pharma 2015-2024
- Premium Statistic Sales revenue Kwang Dong Pharmaceutical 2013-2023
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
Drug consumption
5
- Premium Statistic Pharmaceutical medications taken in South Korea 2019-2022
- Premium Statistic Major pharmaceutical level 1 drugs consumed South Korea 2022
- Premium Statistic Pharmaceutical level 1 drugs consumed South Korea 2022, compared to OECD
- Premium Statistic Major pharmaceutical level 2 drugs consumed South Korea 2022
- Premium Statistic Major pharmaceutical level 3 drugs consumed South Korea 2022
Further related statistics
19
- Celltrion R&D investment South Korea 2013-2017
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Biosimilar market size Japan 2018-2030
- Biopharmaceutical market size forecast Japan 2011-2020
- Share of Novo Nordisk in insulin market in Greater China 2019, by segment
- Biopharmaceuticals market value in Latin America 2022-2027
- Average peak sales forecast per new biopharmaceutical asset 2013-2023
- Operating income Yuhan 2015-2023
- Employment in pharma industry in Colombia 2014-2022
- Net income Yuhan 2015-2023
- Sales revenue from non-prescription drugs Yuhan 2016-2023
- VECOL S.A.: net sales breakdown 2016-2018, by segment
- Pharmaceuticals production value in Colombia 2014-2022
- VECOL S.A.: net income 2016-2018
- Global pharmaceutical excipients markets CAGR forecast 2019-2025
- UK: number of manufacturers of basic pharmaceutical products 2009-2018
- Production value of pharmaceutical products & preparations in Bosnia 2013-2020
- Average deal value of biopharma M&A deals worldwide 2010-2019, by top companies
Further Content: You might find this interesting as well
Statistics
- Celltrion R&D investment South Korea 2013-2017
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Biosimilar market size Japan 2018-2030
- Biopharmaceutical market size forecast Japan 2011-2020
- Share of Novo Nordisk in insulin market in Greater China 2019, by segment
- Biopharmaceuticals market value in Latin America 2022-2027
- Average peak sales forecast per new biopharmaceutical asset 2013-2023
- Operating income Yuhan 2015-2023
- Employment in pharma industry in Colombia 2014-2022
- Net income Yuhan 2015-2023
- Sales revenue from non-prescription drugs Yuhan 2016-2023
- VECOL S.A.: net sales breakdown 2016-2018, by segment
- Pharmaceuticals production value in Colombia 2014-2022
- VECOL S.A.: net income 2016-2018
- Global pharmaceutical excipients markets CAGR forecast 2019-2025
- UK: number of manufacturers of basic pharmaceutical products 2009-2018
- Production value of pharmaceutical products & preparations in Bosnia 2013-2020
- Average deal value of biopharma M&A deals worldwide 2010-2019, by top companies
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$1,299 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
DART. (March 18, 2025). Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2024 (in trillion South Korean won) [Graph]. In Statista. Retrieved April 22, 2025, from https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/
DART. "Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2024 (in trillion South Korean won)." Chart. March 18, 2025. Statista. Accessed April 22, 2025. https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/
DART. (2025). Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2024 (in trillion South Korean won). Statista. Statista Inc.. Accessed: April 22, 2025. https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/
DART. "Sales Revenue of Gc Pharma (Green Cross Corporation) from 2015 to 2024 (in Trillion South Korean Won)." Statista, Statista Inc., 18 Mar 2025, https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/
DART, Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2024 (in trillion South Korean won) Statista, https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/ (last visited April 22, 2025)
Sales revenue of GC Pharma (Green Cross Corporation) from 2015 to 2024 (in trillion South Korean won) [Graph], DART, March 18, 2025. [Online]. Available: https://www.statista.com/statistics/1165947/gc-pharma-sales-revenue/